Legal Opinion
Cadence Pharmaceuticals Inc. v. Exela Pharma Sciences LLC
Court of Appeals for the Federal Circuit
Decided March 23, 2015No. 2014-1184PublishedCited by 28 opinions
1Opinion of the Court
LINN, Circuit Judge.
In this Hatch-Waxman' Act litigation, Exela PharmSci Inc., Exela Holdings, Inc. and Exela Pharm' Sciences, LLC (collectively “Exela”) appéal the district court’s construction of certain claim terms of U.S. Patents No. 6,028,222 (the “'222 patent”) and No. 6,992,218 (the “'218 patent”), Cadence Pharm,., Inc. v. Paddock Labs. Inc., 886 F.Supp.2d 445 (D.Del.2012), and its rulings that Exela infringed certain asserted claims of both patents and failed to prove invalidity as to the 218 patent. Cadence Pharm., Inc. v. Exela Pharma Scis., LLC, No. 11-733-LPS, 2013 U.S. Dist.…
2Cases cited35 opinions
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- Graver Tank & Mfg. Co. v. Linde Air Products Co.Supreme Court of the United States · 1950
- Microsoft Corp. v. i4i Ltd. PartnershipSupreme Court of the United States · 2011
30 more not listed; retrieve them via the Exa API.
3Cited by28 opinions
- Akzo Nobel Coatings, Inc. v. Dow Chemical CompanyCourt of Appeals for the Federal Circuit · 2016
- Avid Technology, Inc. v. Harmonic, Inc.Court of Appeals for the Federal Circuit · 2016
- Huawei Techs., Co. v. Samsung Elecs. Co.District Court, N.D. California · 2018
- Ucb, Inc. v. Watson Laboratories Inc.Court of Appeals for the Federal Circuit · 2019
- Otsuka Pharmaceutical Co. v. Torrent Pharmaceuticals Ltd.District Court, D. New Jersey · 2015
23 more not listed; retrieve them via the Exa API.